171 related articles for article (PubMed ID: 37202386)
1. Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis.
Wu A; Li Z; Wang Y; Chen Y; Peng J; Zhu M; Li Y; Song H; Zhou D; Zhang C; Lv Y; Zhao Z
Cell Death Discov; 2023 May; 9(1):171. PubMed ID: 37202386
[TBL] [Abstract][Full Text] [Related]
2. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
[TBL] [Abstract][Full Text] [Related]
3. A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway.
Zhang CD; Wang YL; Zhou DM; Zhu MY; Lv Y; Hao XQ; Qu CF; Chen Y; Gu WZ; Wu BQ; Chen PC; Zhao ZY
Transl Oncol; 2021 Jul; 14(7):101091. PubMed ID: 33848808
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Chinese Hu191 measles virus exhibits a significant antitumor activity against nephroblastoma mediated by immunogenic form of apoptosis.
Zhu M; Wang Y; Qu C; Liu R; Zhang C; Wang J; Zhou D; Gu W; Chen P; Wu B; Zhao Z
Am J Transl Res; 2021; 13(4):2077-2093. PubMed ID: 34017376
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis.
Zhang CD; Jiang LH; Zhou X; He YP; Liu Y; Zhou DM; Lv Y; Wu BQ; Zhao ZY
Transl Oncol; 2024 Jan; 39():101812. PubMed ID: 37871517
[TBL] [Abstract][Full Text] [Related]
6. Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains.
Lv Y; Zhang CD; Wang YL; Zhou DM; Zhu MY; Hao XQ; Wang JH; Gu WZ; Shen HQ; Lou JG; Wu BQ; Chen PC; Zhao ZY
Gastric Cancer; 2021 Nov; 24(6):1293-1306. PubMed ID: 34251544
[TBL] [Abstract][Full Text] [Related]
7. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
8. Alpinumisoflavone triggers GSDME-dependent pyroptosis in esophageal squamous cell carcinomas.
Zhang B; Zhu WY; Tian H; Zhang HR
Anat Rec (Hoboken); 2021 Feb; 304(2):323-332. PubMed ID: 32396690
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of safety and immunogenicity of the Chinese Hu191 measles virus vaccine by alteration of the S-adenosylmethionine (SAM) binding site in the large polymerase protein.
Wang Y; Liu R; Lu M; Yang Y; Zhou D; Hao X; Zhou D; Wang B; Li J; Huang YW; Zhao Z
Virology; 2018 May; 518():210-220. PubMed ID: 29525671
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
Jiang M; Wu Y; Qi L; Li L; Song D; Gan J; Li Y; Ling X; Song C
Chem Biol Interact; 2021 Dec; 350():109704. PubMed ID: 34655567
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis.
Li L; Song D; Qi L; Jiang M; Wu Y; Gan J; Cao K; Li Y; Bai Y; Zheng T
Cancer Lett; 2021 Nov; 520():143-159. PubMed ID: 34256094
[TBL] [Abstract][Full Text] [Related]
13. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma.
Wu M; Wang Y; Yang D; Gong Y; Rao F; Liu R; Danna Y; Li J; Fan J; Chen J; Zhang W; Zhan Q
EBioMedicine; 2019 Mar; 41():244-255. PubMed ID: 30876762
[TBL] [Abstract][Full Text] [Related]
14. Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
Moritoh K; Shoji K; Amagai Y; Fujiyuki T; Sato H; Yoneda M; Kai C
Cancer Sci; 2023 May; 114(5):2158-2168. PubMed ID: 36715555
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C
Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781
[TBL] [Abstract][Full Text] [Related]
16. Development of new therapy for canine mammary cancer with recombinant measles virus.
Shoji K; Yoneda M; Fujiyuki T; Amagai Y; Tanaka A; Matsuda A; Ogihara K; Naya Y; Ikeda F; Matsuda H; Sato H; Kai C
Mol Ther Oncolytics; 2016; 3():15022. PubMed ID: 27119113
[TBL] [Abstract][Full Text] [Related]
17. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity.
Lin J; Sun S; Zhao K; Gao F; Wang R; Li Q; Zhou Y; Zhang J; Li Y; Wang X; Du L; Wang S; Li Z; Lu H; Lan Y; Song D; Guo W; Chen Y; Gao F; Zhao Y; Fan R; Guan J; He W
Nat Commun; 2023 Jan; 14(1):224. PubMed ID: 36641456
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer.
Li RY; Zheng ZY; Li ZM; Heng JH; Zheng YQ; Deng DX; Xu XE; Liao LD; Lin W; Xu HY; Huang HC; Li EM; Xu LY
Chem Biol Interact; 2022 Jul; 361():109967. PubMed ID: 35525317
[TBL] [Abstract][Full Text] [Related]
20. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
Awano M; Fujiyuki T; Shoji K; Amagai Y; Murakami Y; Furukawa Y; Sato H; Yoneda M; Kai C
Cancer Sci; 2016 Nov; 107(11):1647-1652. PubMed ID: 27561180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
